![Thomas Sciascia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Sciascia
Gründer bei
TREVI THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Thomas R.
Sciascia is the founder of Trevi Therapeutics, Inc., founded in 2011, serving as Chief Scientific Officer since 2022.
Former jobs include Medical Director at Quintiles, Inc. (California) from 1997 to 2000, Medical Director at Transkaryotic Therapies, Inc. from 2000 to 2001, Chief Medical Officer & Senior Vice President at Penwest Pharmaceuticals Co. from 2001 to 2010, and Faculty Member at Boston University from 1983 to 1997.
Education includes a doctorate from The Trustees of Columbia University in The City of New York in 1979 and an undergraduate degree from Massachusetts Institute of Technology in 1975.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC. 0,18 % | 19.02.2026 | 221 373 ( 0,18 % ) | 3 Mio $ | 31.05.2026 |
Aktive Positionen von Thomas Sciascia
| Unternehmen | Position | Beginn |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Gründer | 01.01.2011 |
Ehemalige bekannte Positionen von Thomas Sciascia
| Unternehmen | Position | Ende |
|---|---|---|
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1997 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Thomas Sciascia
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
